About
Tom Stubbs is a UK-based epigenetics entrepreneur and operator focused on biological age, diagnostics, and precision health. City AM described him in June 2019 as a co-founder and CEO of Chronomics and said he held a PhD in epigenetics from Cambridge University. By November 28, 2023, Bayer identified him as CEO of Hurdle, which markets diagnostic and biomarker infrastructure tied to healthy aging and multi-omics testing.
Areas of interest
longevityhealthy agingepigeneticsprecision healthdiagnosticsbiological age testingmulti-omicspreventive health